Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5122838 | 5720172 | F | 2 | 5122838-8 | 20041213 | 20060921 | 20061004 | EXP | 2004BI002016 | BIOGEN IDEC INC. | 21 | YR | F | N | 91 | KG | 20061003 | OT | NORWAY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5122838 | 1007740146 | PS | AVONEX | 1 | INTRAMUSCULAR | 30 UG; QW; IM | N | D | 040099A | 20050701 | |
| 5122838 | 1007762397 | SS | METHYLPREDNISOLONE VS PLACEBO (ALL OTHER THERAPEUTIC PRODUCTS) | 2 | ORAL | 1500 MG; QM; PO | N | D | |||
| 5122838 | 1007762398 | C | TETRACYCLINE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5122838 | 1007740146 | MULTIPLE SCLEROSIS |
| 5122838 | 1007762397 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5122838 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5122838 | ALANINE AMINOTRANSFERASE INCREASED |
| 5122838 | ANTINUCLEAR ANTIBODY POSITIVE |
| 5122838 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 5122838 | AUTOIMMUNE DISORDER |
| 5122838 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 5122838 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
| 5122838 | LABORATORY TEST ABNORMAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5122838 | FGN |
| 5122838 | HP |
| 5122838 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5122838 | 1007740146 | 20040423 | 20041214 | ||
| 5122838 | 1007762397 | 20040622 |